Elisa Murenu

Dr. Elisa Murenu

LMU Klinikum
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
SGSergio Gascón
Sergio Gascón
Elisa MurenuElisa Murenu
Elisa Murenu
GMGiacomo Masserdotti
Giacomo Masserdotti
Felipe OrtegaFelipe Ortega
Felipe Ortega
GRGianluca L. Russo
Gianluca L. Russo
MGMagdalena Götz
Magdalena Götz

1 September 2013 in Experimental Neurology
Verified
Journal Article
Closed access
PSPaola Sgadò
Paola Sgadò
SGSacha Genovesi
Sacha Genovesi
AKAnna Kalinovsky
Anna Kalinovsky
GZGiulia Zunino
Giulia Zunino
FMFrancesca Macchi
Francesca Macchi
YBYuri Bozzi
Yuri Bozzi

16 October 2012 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
MBMichele Bertacchi
Michele Bertacchi
LPLuca Pandolfini
Luca Pandolfini
Elisa MurenuElisa Murenu
Elisa Murenu
AVAlessandro Viegi
Alessandro Viegi
SCSimona Capsoni
Simona Capsoni
FCFederico Cremisi
Federico Cremisi
We investigated the effects of bone morphogenetic proteins (BMPs) in determining the positional identity of neurons generated in vitro from mouse embryonic stem cells (ESCs), an aspect that has been neglected thus far. Classical embryological studies in lower vertebrates indicate that BMPs inhibit the default fate of pluripotent embryonic cells, which is both neural and anterior. Moreover, mammalian ESCs generate neurons more efficiently when cultured in a minimal medium containing BMP inhibitors. In this paper, we show that mouse ESCs produce, secrete, and respond to BMPs during in vitro neural differentiation. After neuralization in a minimal medium, differentiated ESCs show a gene expression profile consistent with a midbrain identity, as evaluated by the analysis of a number of markers of anterior–posterior and dorsoventral identity. We found that BMPs endogenously produced during neural differentiation mainly act by inhibiting the expression of a telencephalic gene profile, which was revealed by the treatment with Noggin or with other BMP inhibitors. To better characterize the effect of BMPs on positional fate, we compared the global gene expression profiles of differentiated ESCs with those of embryonic forebrain, midbrain, and hindbrain. Both Noggin and retinoic acid (RA) support neuronal differentiation of ESCs, but they show different effects on their positional identity: whereas RA supports the typical gene expression profile of hindbrain neurons, Noggin induces a profile characteristic of dorsal telencephalic neurons. Our findings show that endogenously produced BMPs affect the positional identity of the neurons that ESCs spontaneously generate when differentiating in vitro in a minimal medium. The data also support the existence of an intrinsic program of neuronal differentiation with dorsal telencephalic identity. Our method of ESC neuralization allows for fast differentiation of neural cells via the same signals found during in vivo embryonic development and for the acquisition of cortical identity by the inhibition of BMP alone.

Verified
Journal Article
Open access
PDF file
Elisa MurenuElisa Murenu
Elisa Murenu
SKSarantos Kostidis
Sarantos Kostidis
SLShibojyoti Lahiri
Shibojyoti Lahiri
AGAnna S. Geserich
Anna S. Geserich
AIAxel Imhof
Axel Imhof
Stylianos MichalakisStylianos Michalakis
Stylianos Michalakis
Photoreceptors are the light-sensing cells of the retina and the major cell type affected in most inherited retinal degenerations. Different metabolic pathways sustain their high energetic demand in physiological conditions, particularly aerobic glycolysis. The principal metabolome of the mature retina has been studied, but only limited information is available on metabolic adaptations in response to key developmental events, such as eye opening. Moreover, dynamic metabolic changes due to retinal degeneration are not well understood. Here, we aimed to explore and map the ocular metabolic dynamics induced by eye opening in healthy (wild type) or Pde6b-mutant (retinal degeneration 1, Rd1) mice, in which photoreceptors degenerate shortly after eye opening. To unravel metabolic differences emerging before and after eye opening under physiological and pathophysiological conditions, we performed nuclear magnetic resonance (NMR) spectrosco-py-based metabolome analysis of wild type and Rd1 retina and vitreous/lens. We show that eye opening is accompanied by changes in the concentration of selected metabolites in the retina and by alterations in the vitreous/lens composition only in the retinal degeneration context. As such, we identify N-Acetylaspartate as a potential novel vitreous/lens marker reflecting progressive retinal degeneration. Thus, our data can help elucidating mechanisms underlying key events in retinal physiology and reveal changes occurring in pathology, while highlighting the importance of the vitreous/lens in the characterization of retinal diseases.

Verified
Journal Article
Open access
PDF file
MKMirja Koch
Mirja Koch
CSConstanze Scheel
Constanze Scheel
HMHongwei Ma
Hongwei Ma
FYFan Yang
Fan Yang
MSMichael Stadlmeier
Michael Stadlmeier
Stylianos MichalakisStylianos Michalakis
Stylianos Michalakis
Mutations in the CNGA3 gene, which encodes the A subunit of the cyclic guanosine monophosphate (cGMP)-gated cation channel in cone photoreceptor outer segments, cause total colour blindness, also referred to as achromatopsia. Cones lacking this channel protein are non-functional, accumulate high levels of the second messenger cGMP and degenerate over time after induction of ER stress. The cell death mechanisms that lead to loss of affected cones are only partially understood. Here, we explored the disease mechanisms in the Cnga3 knockout (KO) mouse model of achromatopsia. We found that another important effector of cGMP, the cGMP-dependent protein kinase 2 (Prkg2) is crucially involved in cGMP cytotoxicity of cones in Cnga3 KO mice. Virus-mediated knockdown or genetic ablation of Prkg2 in Cnga3 KO mice counteracted degeneration and preserved the number of cones. Analysis of markers of endoplasmic reticulum stress and unfolded protein response confirmed that induction of these processes in Cnga3 KO cones also depends on Prkg2. In conclusion, we identified Prkg2 as a novel key mediator of cone photoreceptor degeneration in achromatopsia. Our data suggest that this cGMP mediator could be a novel pharmacological target for future neuroprotective therapies.

1 March 2021 in Molecular Therapy - Methods & Clinical Development
Verified
Journal Article
Open access
Elisa MurenuElisa Murenu
Elisa Murenu
MPMarina Pavlou
Marina Pavlou
LRLisa Richter
Lisa Richter
KRKleopatra Rapti
Kleopatra Rapti
SJSabrina Just
Sabrina Just
Stylianos MichalakisStylianos Michalakis
Stylianos Michalakis
Inherited retinal dystrophies (IRDs) are characterized by progressive degeneration and loss of light-sensing photoreceptors. The most promising therapeutic approach for IRDs is gene supplementation therapy using viral vectors, which requires the presence of viable photoreceptors at the time of intervention. At later disease stages, photoreceptors are lost and can no longer be rescued with this approach. For these patients, conferring light-sensing abilities to the remaining interneurons of the ON circuit (i.e., ON bipolar cells) using optogenetic tools poses an alternative treatment strategy. Such treatments, however, are hampered by the lack of efficient gene delivery tools targeting ON bipolar cells, which in turn rely on the effective isolation of these cells to facilitate tool development. Herein, we describe a method to selectively isolate ON bipolar cells via fluorescence-activated cell sorting (FACS), based on the expression of two intracellular markers. We show that the method is compatible with highly sensitive downstream analyses and suitable for the isolation of ON bipolar cells from healthy as well as degenerated mouse retinas. Moreover, we demonstrate that this approach works effectively using non-human primate (NHP) retinal tissue, thereby offering a reliable pipeline for universal screening strategies that do not require inter-species adaptations or transgenic animals.